Literature DB >> 22354485

Skip lateral neck node metastases in papillary thyroid carcinoma.

Jae Hyun Park1, Yong Sang Lee, Bup Woo Kim, Hang-Seok Chang, Cheong Soo Park.   

Abstract

BACKGROUND: Papillary thyroid carcinomas (PTCs) are commonly associated with lymph node metastases (LNMs), which are thought to disseminate sequentially, first to the central compartment and later to the lateral compartment. However, a small number of patients have skip metastases to the lateral compartment without central LNMs. This study was performed to evaluate the clinicopathologic characteristics of skip metastases in PTC.
METHODS: We reviewed the medical records of 147 patients who underwent total thyroidectomy with central neck dissection plus modified radical neck dissection (RND) for PTC. A single surgeon performed all operations. The patients were classified as either present or absent skip metastases. The clinicopathologic characteristics were statistically analyzed.
RESULTS: Skip metastases were found in 32 patients (21.8%) and occurred commonly with primary tumors of the upper pole, and with tumors ≤1 cm in diameter. Skip metastases were less common in patients with multifocal disease. Patients with skip metastases had fewer metastatic lateral nodes that were more frequently found at a single level: mostly at level III (96.9%) and level II (34.4%).
CONCLUSIONS: Although skip metastases occur in only a small number of patients, the lateral compartment should be carefully evaluated for skip metastases, even though primary tumors are either single focus, located in the upper pole, or ≤1 cm in diameter.

Entities:  

Mesh:

Year:  2012        PMID: 22354485     DOI: 10.1007/s00268-012-1476-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

1.  Extent of surgery for intermediate-risk well-differentiated thyroid cancer.

Authors:  S Beenken; D Roye; H Weiss; M Sellers; M Urist; A Diethelm; H Goepfert
Journal:  Am J Surg       Date:  2000-01       Impact factor: 2.565

2.  Papillary carcinoma of the thyroid. I. Developing pattern of metastasis.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

3.  Lymph node metastases from well-differentiated thyroid cancer. A clinical review.

Authors:  G I McGregor; A Luoma; S M Jackson
Journal:  Am J Surg       Date:  1985-05       Impact factor: 2.565

4.  Neck dissection for surgical treatment of lymphnode metastasis in papillary thyroid carcinoma.

Authors:  M Ducci; M Appetecchia; M Marzetti
Journal:  J Exp Clin Cancer Res       Date:  1997-09

5.  Papillary microcarcinoma of the thyroid: how should it be treated?

Authors:  Yasuhiro Ito; Chisato Tomoda; Takashi Uruno; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal:  World J Surg       Date:  2004-11       Impact factor: 3.352

6.  Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.

Authors:  Marc Riquet; Jalal Assouad; Patrick Bagan; Christophe Foucault; Françoise Le Pimpec Barthes; Antoine Dujon; Claire Danel
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

7.  Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.

Authors:  Sally E Carty; David S Cooper; Gerard M Doherty; Quan-Yang Duh; Richard T Kloos; Susan J Mandel; Gregory W Randolph; Brendan C Stack; David L Steward; David J Terris; Geoffrey B Thompson; Ralph P Tufano; R Michael Tuttle; Robert Udelsman
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

Review 8.  Lateral lymph node dissection guided by preoperative and intraoperative findings in differentiated thyroid carcinoma.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

9.  Skip metastases in thyroid cancer leaping the central lymph node compartment.

Authors:  Andreas Machens; Hans-Jürgen Holzhausen; Henning Dralle
Journal:  Arch Surg       Date:  2004-01

10.  Prognostic factors determining long-term survival in well-differentiated thyroid cancer: an analysis of four hundred eighty-four patients undergoing therapy and aftercare at the same institution.

Authors:  Waltraud Eichhorn; Harry Tabler; Rainer Lippold; Matthias Lochmann; Mathias Schreckenberger; Peter Bartenstein
Journal:  Thyroid       Date:  2003-10       Impact factor: 6.568

View more
  38 in total

1.  [Lateral skip metastases in papillary thyroid carcinoma].

Authors:  H Dralle
Journal:  Chirurg       Date:  2012-07       Impact factor: 0.955

2.  Clinical characteristics and surgical resection of multifocal papillary thyroid carcinoma: 168 cases.

Authors:  Guomin Huang; Xiaofeng Tian; Yuhui Li; Fujian Ji
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Pathologic reporting of lymph node metastases in differentiated thyroid cancer: a call to action for the College of American Pathologists.

Authors:  Mark L Urken; Jeffery I Mechanick; Jonathan Sarlin; Sophie Scherl; Bruce M Wenig
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 4.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

5.  [Total thyroidectomy with lymph node dissection of the central compartment for node-positive, capsular invasive papillary thyroid cancer: video contribution].

Authors:  H Dralle; P Nguyen Thanh
Journal:  Chirurg       Date:  2014-10       Impact factor: 0.955

Review 6.  Differentiated and Medullary Thyroid Cancer: Surgical Management of Cervical Lymph Nodes.

Authors:  P Asimakopoulos; I J Nixon; A R Shaha
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-01-13       Impact factor: 4.126

Review 7.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 8.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

Review 9.  Management of the Neck in Well-Differentiated Thyroid Cancer.

Authors:  Panagiotis Asimakopoulos; Ashok R Shaha; Iain J Nixon; Jatin P Shah; Gregory W Randolph; Peter Angelos; Mark E Zafereo; Luiz P Kowalski; Dana M Hartl; Kerry D Olsen; Juan P Rodrigo; Vincent Vander Poorten; Antti A Mäkitie; Alvaro Sanabria; Carlos Suárez; Miquel Quer; Francisco J Civantos; K Thomas Robbins; Orlando Guntinas-Lichius; Marc Hamoir; Alessandra Rinaldo; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-11-14       Impact factor: 5.075

10.  Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.

Authors:  Jia-Wei Feng; An-Cheng Qin; Jing Ye; Hua Pan; Yong Jiang; Zhen Qu
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.